AlphaCrest Capital Management’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,962
Closed -$274K 1418
2021
Q4
$274K Sell
6,962
-5,138
-42% -$225K 0.01% 1277
2021
Q3
$590K Sell
12,100
-8,538
-41% -$442K 0.03% 844
2021
Q2
$1.08M Buy
+20,638
New +$1.18M 0.05% 627
2020
Q4
Sell
-31,500
Closed -$584K 1284
2020
Q3
$584K Buy
31,500
+18,600
+144% +$308K 0.06% 502
2020
Q2
$178K Sell
12,900
-24,400
-65% -$330K 0.03% 853
2020
Q1
$342K Buy
37,300
+25,100
+206% +$376K 0.04% 739
2019
Q4
$212K Sell
12,200
-4,500
-27% -$76.6K 0.02% 1194
2019
Q3
$253K Buy
+16,700
New +$292K 0.02% 1148
2019
Q2
Sell
-21,700
Closed -$380K 1143
2019
Q1
$380K Buy
+21,700
New +$397K 0.06% 573

Other funds holding VCEL

AlphaCrest Capital Management's VCEL Position: Q1 2022 in Review

AlphaCrest Capital Management sold out of Vericel Corp (VCEL) in Q1 2022, closing a stake of 6,962 shares — an estimated $274K sold.

AlphaCrest Capital Management first reported a position in VCEL in Q1 2019 and held it in 9 quarters. The position peaked at $1.08M in Q2 2021. 198 funds tracked by Wall St. Rank hold VCEL as of Q1 2022.

  • AlphaCrest Capital Management reported no remaining Vericel Corp position as of Q1 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 6,962 Vericel Corp shares in Q1 2022, an estimated $274K.
  • AlphaCrest Capital Management first reported a position in Vericel Corp in Q1 2019 and held it in 9 quarters.
  • AlphaCrest Capital Management's Vericel Corp position peaked at $1.08M in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2022.

Based on AlphaCrest Capital Management's 13F filing for Q1 2022, filed 12 May 2022.